TW201831166A - 含提升人參皂苷含量之人參花萃取物之組成物 - Google Patents

含提升人參皂苷含量之人參花萃取物之組成物 Download PDF

Info

Publication number: TW201831166A
Authority: TW; Taiwan
Prior art keywords: composition; weight; parts; ginseng flower; extraction
Prior art date: 2017-01-26

Application number

TW107102194A

Other languages

English (en)

Chinese (zh)

Inventor

金東泫

金炫秀

南基帛

朴錄賢

朴浚星

李垠秀

Original Assignee

南韓商愛茉莉太平洋股份有限公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-01-26

Filing date

2018-01-22

Publication date

2018-09-01

2018-01-22 Application filed by 南韓商愛茉莉太平洋股份有限公司 filed Critical 南韓商愛茉莉太平洋股份有限公司

2018-09-01 Publication of TW201831166A publication Critical patent/TW201831166A/zh

Links

235000008434 ginseng Nutrition 0.000 title claims abstract description 142
235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 140
235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 140
239000000203 mixture Substances 0.000 title claims abstract description 96
239000000284 extract Substances 0.000 title claims abstract description 92
241000208340 Araliaceae Species 0.000 title claims abstract 8
229930182494 ginsenoside Natural products 0.000 title abstract description 22
229940089161 ginsenoside Drugs 0.000 title abstract description 12
238000000034 method Methods 0.000 claims abstract description 31
230000008591 skin barrier function Effects 0.000 claims abstract description 29
230000002708 enhancing effect Effects 0.000 claims abstract description 17
102000044503 Antimicrobial Peptides Human genes 0.000 claims abstract description 15
108700042778 Antimicrobial Peptides Proteins 0.000 claims abstract description 15
239000003910 polypeptide antibiotic agent Substances 0.000 claims abstract description 14
102000005871 S100 Calcium Binding Protein A7 Human genes 0.000 claims abstract description 11
108090000623 proteins and genes Proteins 0.000 claims abstract description 11
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims abstract description 10
229940030793 psoriasin Drugs 0.000 claims abstract description 10
108010005256 S100 Calcium Binding Protein A7 Proteins 0.000 claims abstract description 8
230000014509 gene expression Effects 0.000 claims abstract description 6
238000000605 extraction Methods 0.000 claims description 106
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 claims description 26
AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 claims description 26
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
239000003960 organic solvent Substances 0.000 claims description 15
239000002904 solvent Substances 0.000 claims description 15
101000912247 Homo sapiens Beta-defensin 103 Proteins 0.000 claims description 13
101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 claims description 13
239000004480 active ingredient Substances 0.000 claims description 13
102000055779 human DEFB103A Human genes 0.000 claims description 13
102000049262 human DEFB4A Human genes 0.000 claims description 12
239000002537 cosmetic Substances 0.000 claims description 11
239000002994 raw material Substances 0.000 claims description 11
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 10
239000000460 chlorine Substances 0.000 claims description 10
229910052801 chlorine Inorganic materials 0.000 claims description 10
229930182490 saponin Natural products 0.000 claims description 8
150000007949 saponins Chemical class 0.000 claims description 8
235000013305 food Nutrition 0.000 claims description 7
239000001397 quillaja saponaria molina bark Substances 0.000 claims description 7
239000008194 pharmaceutical composition Substances 0.000 claims description 6
TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims description 5
YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 5
238000004508 fractional distillation Methods 0.000 claims description 3
FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 claims description 2
FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 claims description 2
UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims description 2
HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 claims description 2
YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 2
125000003158 alcohol group Chemical group 0.000 claims description 2
GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims description 2
NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 claims description 2
PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 claims description 2
CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims description 2
ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 claims description 2
UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 claims description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
239000005977 Ethylene Substances 0.000 claims 1
230000004888 barrier function Effects 0.000 abstract description 6
230000000845 anti-microbial effect Effects 0.000 abstract description 4
239000004599 antimicrobial Substances 0.000 abstract description 3
240000004371 Panax ginseng Species 0.000 description 134
230000000052 comparative effect Effects 0.000 description 29
239000000843 powder Substances 0.000 description 26
238000002360 preparation method Methods 0.000 description 21
238000012360 testing method Methods 0.000 description 21
238000009472 formulation Methods 0.000 description 19
230000006837 decompression Effects 0.000 description 13
238000007796 conventional method Methods 0.000 description 12
230000001965 increasing effect Effects 0.000 description 9
239000004615 ingredient Substances 0.000 description 9
210000003491 skin Anatomy 0.000 description 9
230000000694 effects Effects 0.000 description 8
230000008569 process Effects 0.000 description 8
239000008187 granular material Substances 0.000 description 7
235000017709 saponins Nutrition 0.000 description 7
239000007787 solid Substances 0.000 description 7
238000004128 high performance liquid chromatography Methods 0.000 description 6
241000196324 Embryophyta Species 0.000 description 5
239000000839 emulsion Substances 0.000 description 5
210000002510 keratinocyte Anatomy 0.000 description 5
239000012071 phase Substances 0.000 description 5
238000003809 water extraction Methods 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
101000869689 Homo sapiens Protein S100-A7 Proteins 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000006071 cream Substances 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
229910021641 deionized water Inorganic materials 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
239000000463 material Substances 0.000 description 4
239000002674 ointment Substances 0.000 description 4
239000002244 precipitate Substances 0.000 description 4
208000017520 skin disease Diseases 0.000 description 4
239000003826 tablet Substances 0.000 description 4
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
235000002789 Panax ginseng Nutrition 0.000 description 3
239000002775 capsule Substances 0.000 description 3
235000013736 caramel Nutrition 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
229940107131 ginseng root Drugs 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000006210 lotion Substances 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
239000006187 pill Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
201000004681 Psoriasis Diseases 0.000 description 2
244000269722 Thea sinensis Species 0.000 description 2
230000003078 antioxidant effect Effects 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
239000000872 buffer Substances 0.000 description 2
229930002875 chlorophyll Natural products 0.000 description 2
235000019804 chlorophyll Nutrition 0.000 description 2
ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
235000008504 concentrate Nutrition 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
235000013399 edible fruits Nutrition 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
239000008103 glucose Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
239000007902 hard capsule Substances 0.000 description 2
239000003906 humectant Substances 0.000 description 2
206010021198 ichthyosis Diseases 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000008101 lactose Substances 0.000 description 2
229940041476 lactose 100 mg Drugs 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
239000006186 oral dosage form Substances 0.000 description 2
239000006201 parenteral dosage form Substances 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
238000012545 processing Methods 0.000 description 2
239000007901 soft capsule Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
230000002195 synergetic effect Effects 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
102100040881 60S acidic ribosomal protein P0 Human genes 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
102000000541 Defensins Human genes 0.000 description 1
108010002069 Defensins Proteins 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
244000133098 Echinacea angustifolia Species 0.000 description 1
241001632410 Eleutherococcus senticosus Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
101000673456 Homo sapiens 60S acidic ribosomal protein P0 Proteins 0.000 description 1
208000017657 Menopausal disease Diseases 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
102000013674 S-100 Human genes 0.000 description 1
108700021018 S100 Proteins 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
206010048218 Xeroderma Diseases 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000006096 absorbing agent Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
206010000496 acne Diseases 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
230000003712 anti-aging effect Effects 0.000 description 1
230000000489 anti-atherogenic effect Effects 0.000 description 1
230000000879 anti-atherosclerotic effect Effects 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
230000003217 anti-cancerogenic effect Effects 0.000 description 1
230000003178 anti-diabetic effect Effects 0.000 description 1
230000002929 anti-fatigue Effects 0.000 description 1
230000001166 anti-perspirative effect Effects 0.000 description 1
230000002180 anti-stress Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000003213 antiperspirant Substances 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
102000012265 beta-defensin Human genes 0.000 description 1
108050002883 beta-defensin Proteins 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000000692 cap cell Anatomy 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
210000003763 chloroplast Anatomy 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000002826 coolant Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
238000011161 development Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
239000006196 drop Substances 0.000 description 1
-1 dusts Substances 0.000 description 1
235000014134 echinacea Nutrition 0.000 description 1
230000002876 effect on osteoporosis Effects 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
210000004920 epithelial cell of skin Anatomy 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
235000021107 fermented food Nutrition 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
239000003292 glue Substances 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
150000002338 glycosides Chemical class 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000036541 health Effects 0.000 description 1
235000001497 healthy food Nutrition 0.000 description 1
241000411851 herbal medicine Species 0.000 description 1
235000008216 herbs Nutrition 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
239000001023 inorganic pigment Substances 0.000 description 1
235000021109 kimchi Nutrition 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000003908 liver function Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000013310 margarine Nutrition 0.000 description 1
239000003264 margarine Substances 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000012046 mixed solvent Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000012454 non-polar solvent Substances 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
239000012860 organic pigment Substances 0.000 description 1
239000003002 pH adjusting agent Substances 0.000 description 1
239000002304 perfume Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000009290 primary effect Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011946 reduction process Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
230000036559 skin health Effects 0.000 description 1
235000020712 soy bean extract Nutrition 0.000 description 1
229940083466 soybean lecithin Drugs 0.000 description 1
150000003408 sphingolipids Chemical class 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
235000013616 tea Nutrition 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Medicinal Chemistry (AREA)
Botany (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Birds (AREA)
Microbiology (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Medical Informatics (AREA)
Food Science & Technology (AREA)
Alternative & Traditional Medicine (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Cosmetics (AREA)
Medicines Containing Plant Substances (AREA)

TW107102194A 2017-01-26 2018-01-22 含提升人參皂苷含量之人參花萃取物之組成物 TW201831166A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
??10-2017-0013027		2017-01-26
KR1020170013027A KR102175469B1 (ko)	2017-01-26	2017-01-26	진세노사이드 함량이 증진된 인삼꽃 추출물을 유효성분으로 포함하는 조성물

Publications (1)

Publication Number	Publication Date
TW201831166A true TW201831166A (zh)	2018-09-01

Family

ID=62978052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW107102194A TW201831166A (zh)	2017-01-26	2018-01-22	含提升人參皂苷含量之人參花萃取物之組成物

Country Status (4)

Country	Link
KR (1)	KR102175469B1 (fr)
CN (1)	CN110234332A (fr)
TW (1)	TW201831166A (fr)
WO (1)	WO2018139809A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102287389B1 (ko)	2019-07-06	2021-08-06	재단법인 경북바이오산업연구원	인삼 꽃봉오리 추출물을 유효성분으로 함유하는 항균 조성물
KR102760563B1 (ko)	2022-01-18	2025-02-03	주식회사 한국인삼공사	인삼꽃 추출물의 분획물을 포함하는 조성물
KR102855855B1 (ko)	2022-01-18	2025-09-05	주식회사 한국인삼공사	인삼꽃 추출물의 분획물을 포함하는 피부 미백용 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20090129928A (ko) *	2008-06-13	2009-12-17	(주)아모레퍼시픽	인삼 꽃 추출물을 함유하는 피부 외용제 조성물
CN103479694B (zh) *	2008-06-13	2016-06-29	株式会社爱茉莉太平洋	含有人参的花或人参的种子提取物的皮肤外用剂组合物
KR101860109B1 (ko) *	2011-09-22	2018-05-21	(주)아모레퍼시픽	플로랄진세노사이드를 함유하는 피부 외용제 조성물
KR20130039470A (ko)	2011-10-12	2013-04-22	(주)아모레퍼시픽	백미증법을 이용한 인삼 추출물의 추출방법
KR101374351B1 (ko) *	2012-01-31	2014-03-19	주식회사 씨오투바이오	흑인삼꽃봉오리 추출물을 유효성분으로 함유하는 아토피질환 치료 및 예방용 조성물
KR101663946B1 (ko) *	2014-02-28	2016-10-24	주식회사 코리아나화장품	인삼꽃 흑효모 발효를 통한 진세노사이드 Rg3 강화 및 이를 유효성분으로 함유하는 화장료 조성물
KR102395982B1 (ko) *	2015-01-09	2022-05-11	(주)아모레퍼시픽	진세노사이드 함량이 증진된 인삼 추출물을 유효성분으로 포함하는 조성물

2017
- 2017-01-26 KR KR1020170013027A patent/KR102175469B1/ko active Active
2018
- 2018-01-19 CN CN201880008676.1A patent/CN110234332A/zh active Pending
- 2018-01-19 WO PCT/KR2018/000880 patent/WO2018139809A1/fr not_active Ceased
- 2018-01-22 TW TW107102194A patent/TW201831166A/zh unknown

Also Published As

Publication number	Publication date
KR20180088226A (ko)	2018-08-03
CN110234332A (zh)	2019-09-13
WO2018139809A1 (fr)	2018-08-02
KR102175469B1 (ko)	2020-11-06

Publication	Publication Date	Title
CN102458434B (zh)	2015-03-25	用于提高皂素的生物利用度的组合物
KR101651833B1 (ko)	2016-09-19	감귤류 과피 추출물을 포함하는 탈모 방지 또는 발모 촉진용 조성물
HUE027734T2 (en)	2016-11-28	Piceatannol-containing compositions and method for producing a piceatannol-containing composition
TWI648057B (zh)	2019-01-21	用於緩解經前症候群以及經痛之組合物
WO2005072684A1 (fr)	2005-08-11	Procédé de production de l'extrait de maca
TW201831166A (zh)	2018-09-01	含提升人參皂苷含量之人參花萃取物之組成物
KR101794006B1 (ko)	2017-11-07	식물 추출물을 포함하는 염증 개선용 조성물
CN105147702B (zh)	2018-05-11	神经酰胺产生促进剂以及保湿剂
KR101525877B1 (ko)	2015-06-03	피부 주름 개선 및 피부 노화 방지를 위한 조성물
KR20180007834A (ko)	2018-01-24	인삼 꽃대 추출물을 포함하는 세포 재생용 조성물
JP6647292B2 (ja)	2020-02-14	スクテラリア・アルピナ抽出物を含む脱毛防止または育毛促進用組成物
KR20180114629A (ko)	2018-10-19	인삼 꽃대 추출물을 포함하는 항염증용 조성물
KR102078412B1 (ko)	2020-02-17	황금찰수수 추출물 또는 그 분획물을 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물
KR20100043723A (ko)	2010-04-29	원적외선 처리를 통한 프로토페낙사디올 진세노사이드 성분이 증가된 인삼 잎의 제조방법
TW201729825A (zh)	2017-09-01	含有人參花軸萃取物之促進毛髮生長或預防脫髮的組合物
WO2004019962A1 (fr)	2004-03-11	Stimulants de croissance capillaire administres par voie orale
KR20220043660A (ko)	2022-04-05	에피카테킨을 고함량으로 포함하는 콩 신품종
KR102712426B1 (ko)	2024-10-02	특정 진세노사이드 함유 홍삼 엑기스 및 이를 적용한 식음료 조성물
JP2008081440A (ja)	2008-04-10	アロマターゼ活性促進剤
JP2002017299A (ja)	2002-01-22	健康食品
KR20210016776A (ko)	2021-02-17	녹용 농축물의 제조 방법
EP4142762B1 (fr)	2025-01-29	Superaliment pour prolonger la longévité d'un individu
JP7598613B2 (ja)	2024-12-12	Ａｔｐ産生促進剤
KR20250064313A (ko)	2025-05-09	접시꽃 유래 폴리사카라이드를 함유하는 피부 보습 또는 장벽 강화용 화장료 조성물 및 이의 제조방법
KR20240117022A (ko)	2024-07-31	산양파를 유효성분으로 함유하는 근육 질환 개선, 치료 또는 예방용, 또는 근 기능 개선용 조성물